Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenogratfs

Han Shuyan; Zhao Wei; Hong Sun; An Guo; Li Pingping

Chinese︱Feedback︱Save this page

• Elaborating Academic Views 　　　　 • Exchanging Innovative Ideas
• Protecting Intellectual Properties 　　• Fast Sharing Science Papers

Sponsored by the Center for Science and Technology Development of the Ministry of Education
Supervised by Ministry of Education of the People's Republic of China

Home > Papers

Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenogratfs

Han Shuyan 1 #,Zhao Wei 2,Hong Sun 1,An Guo 3,Li Pingping 1 *

1.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine,Peking University Cancer Hospital & Institute.Beijing 100142

2.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Cell Biology,Peking University Cancer Hospital & Institute.Beijing 100142

3.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory Animal Unit,Peking University Cancer Hospital & Institute.Beijing 100142

*Correspondence author

#Submitted by

Subject:

Funding: 高等学校博士学科点专项科研基金（No.20110001120100),国家自然科学基金面上项目）

Opened online:31 December 2014

Accepted by: none

Citation: Han Shuyan,Zhao Wei,Hong Sun.Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenogratfs[OL]. [31 December 2014] http://en.paper.edu.cn/en_releasepaper/content/4625452

The stem of Marsdenia tenacissima (Roxb.) Wight et Arn. has long been used as a medicine to treat cancer in China. Our previous results showed that Marsdenia tenacissima extract (MTE) overcomes gefitinib resistance in NSCLC cells. The present study investigated in vivo anti-tumor activity of MTE combined with gefitinib. H460 (K-ras mutation) or H1975 cells (T790M mutation) was subcutaneously inoculated into nude mice. Tumor volume and body weight were measured during the experiment. The resected tumors were weighed after animals were sacrificed. Cellular proliferation and apoptosis in xenografts tumor tissue were assessed. EGFR downstream pathways and c-Met expression was evaluated by western blotting. In accordance with the previous in vitro study, MTE at low dose (5 g/kg) was chosen to assess whether it can restore gefitinib sensitivity in vivo. Interestingly, MTE prominently enhanced gefitinib efficacy in the resistant H460 and H1975 xenografts. This combination significantly inhibited tumor proliferation and induced cell apoptosis in both resistant NSCLC xenografts. Constitutive activation of PI3K/Akt and MEK/ERK pathway is related to EGFR-TKI resistance. Accordingly, phosphorylation of PI3K/Akt/mTOR and ERK1/2 was suppressed after the combined treatment. Simultaneously, the cross-talked c-Met and EGFR was also prominently lowered in the presence of MTE combined with gefitinib. This study provides in vivo evidence to demonstrate that MTE enhancing gefitinib efficacy in the resistant NSCLC xenografts, and suggests the combination of MTE and gefitinib as a promising approach against NSCLC.

Keywords:Marsdenia tenacissima extract; gefitinib resistance; NSCLC xenografts; H1975; H460

For this paper

● PDF (0B)
● Revision 0 　　
● Print this paper
● Recommend this paper to a friend
● Add to my favorite list

Saved Papers

Please enter a name for this paper to be shown in your personalized Saved Papers list

Tags

Add yours

Related Papers

Other similar papers

Statistics

PDF Downloaded	164
Bookmarked	0
Recommend	5
Comments	Array

Submit your papers

Alert Name:
Alerting to:
Authentication email will be sent to your email address in 24 hours
Frequency:
Email Message Format:	Plain text Graphical(HTML)

Complete the form below and we will recommend the selected titles to your friends on your behalf. * Indicates a required field.
Your name*:
Your email address*:
Recipient's name*:
Recipient's email address*:
(multiple recipient's names and email addresses should be separated with semicolons)
Your comments:	I thought you would find the page(s) useful.

Your name:
Your email address:
Recipient's name:
Recipient's email address:
(multiple recipient's names and email addresses should be separated with semicolons)
Your comments:	I thought you would find this page useful.

Disclaimer: This message was sent to your friend using the "Send it to a friend" facility on the Sciencepaper Online’ WWW site, http://www.paper.edu.cn/en. The Sciencepaper Online is not responsible for the content of this email, and anything said in this email does not necessarily reflect the Sciencepaper Online's views.

	Check out RSS, or use RSS reader to subscribe this item

Saved Papers